The proposed project consists of the construction of an 8,000 sq. ft. expansion to an existing facility located in the Town of Newstead which facility will be leased to Athenex Pharma Solutions. Athenex currently operates out of 18,500 sq. ft. of space at the same location. The increased square footage is necessary for Athenex' anticipated growth.
Athenex is a global specialty oncology pharmaceutical company focused on the development and commercialization of next generation therapies for cancer diseases and supportive therapies. Athenex began as a University of Buffalo startup, Kinex Pharmaceuticals, and has product manufacturing facilities both in the U.S. and China.
New York State is investing $200 million to construct a facility in the Dunkirk area which will create a High Pharmacy Oncology Manufacturing Facility. Athenex will manufacture sterile, high potency oncology drugs in a specialized, controlled environment.
In addition, New York State has invested $25 million to expand and improve the 6th floor of the Conventus building on the Buffalo Niagara Medical Campus for Athenex' s North American headquarters.
